Therapy News and Research

RSS

Roundup: Calif. mental hospitals released from fed oversight; Kansas hospitals cooperate to recruit rural docs; Va. abortion law questions

A U.S. District Court judge Monday released the state's mental hospitals from federal oversight on all but one issue -- a significant step in ending a costly six-year reform effort. The extensive court-supervised changes were imposed on four hospitals in 2006 as part of a settlement to a lawsuit by the U.S. Department of Justice. The department alleged that the state was violating patients' civil rights by heavily drugging and improperly restraining them and failing to provide appropriate treatment.

26 Sep 2012

Warfarin therapy should not be stopped completely after GI bleeding

The decision to not resume warfarin therapy following a gastrointestinal bleeding event is linked to an increased risk for thrombosis and mortality, researchers suggest.

25 Sep 2012

Daytime oxygen link to poor sleep in COPD

Patients with chronic obstructive pulmonary disease experience poorer sleep quality than those without the disease, say the authors of an Irish study.

25 Sep 2012

Osteopathic manipulation improves spine mobility in obese

Osteopathic manipulative therapy, when combined with specific exercises, has an added benefit of improving kinematics of the thoracic spine in obese patients with chronic low back pain, Italian study findings show.

25 Sep 2012

OncoSec establishes UW as second enrolling site for OMS-I100 Phase II metastatic melanoma trial

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that it has established the University of Washington (UW) as the second enrolling site for its Phase II metastatic melanoma clinical trial (OMS-I100).

25 Sep 2012

UH Case Medical Center offers per-oral endoscopic myotomy for achalasia

University Hospitals (UH) Case Medical Center is one of five institutions nationwide performing a novel scarless procedure that restores swallowing function in some patients with achalasia, a rare condition where the esophagus is unable to move food into the stomach.

25 Sep 2012

ProMedica invests $710,000 in new cancer and infusion center in Fostoria, Ohio

Cancer patients in Fostoria, Ohio, now have access to advanced cancer treatment and protocols close to home. The ProMedica Cancer Institute has invested $710,000 in a new cancer and infusion center in Fostoria, Ohio. The rural community has a population of 13,000 residents.

25 Sep 2012

New KSU molecule may deliver drugs inside the body to treat diseases

Kansas State University researchers have discovered a molecule that may be capable of delivering drugs inside the body to treat diseases.

25 Sep 2012

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.

25 Sep 2012

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

Watch out, acne. Doctors soon may have a new weapon against zits: a harmless virus living on our skin that naturally seeks out and kills the bacteria that cause pimples.

25 Sep 2012

Celleration introduces new MIST 360 Applicator

Celleration, Inc., a privately held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announces the launch of its new MIST 360 Applicator.

25 Sep 2012

Anti-androgen therapies may benefit bladder cancer patients

Bladder cancer patients whose tumors express high levels of the protein CD24 have worse prognoses than patients with lower CD24. A University of Colorado Cancer Center study published today in the Proceedings of the National Academy of Sciences shows that CD24 expression may depend on androgens - and that anti-androgen therapies like those currently used to treat prostate cancer may benefit bladder cancer patients.

25 Sep 2012

Combination of healing touch and guided imagery reduces depression, cynicism among US Marines

Healing touch combined with guided imagery (HT+GI) provides significant clinical reductions in post-traumatic stress disorder (PTSD) symptoms for combat-exposed active duty military, according to a study released in the September issue of Military Medicine.

25 Sep 2012

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

25 Sep 2012

Extended release exenatide outperforms twice daily regimen

Once-weekly extended-release exenatide is a more effective treatment than twice-daily exenatide at improving glucose control among Japanese individuals with diabetes, report researchers.

24 Sep 2012

Absence of proteinuria good prognostic sign in IgA nephropathy

The presence of normal renal function and minor urinary abnormalities indicates a good long-term prognosis among Caucasian patients with immunoglobulin A nephropathy, say Spanish researchers.

24 Sep 2012

PPI use linked with risk for infection in decompensated cirrhosis

Proton-pump inhibitors are associated with an increased risk for serious infections in patients with decompensated cirrhosis, research shows.

24 Sep 2012

Bone marrow transplants hold promise for sickle cell patients

Research shows that even partially matched bone marrow transplants are able to eliminate sickle cell disease in some patients with sickle cell anemia.

24 Sep 2012

No time to lose in basilar artery occlusion treatment

Patients with basilar artery occlusion should undergo recanalization therapy as soon as possible, show data from BASICS.

24 Sep 2012

ESMO Designated Center of Integrated Oncology and Palliative Care accreditation for 16 new centers

The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.

24 Sep 2012